PerkinElmer Collaborates with Helix to Drive Innovation in Exome-Based Personal Genomics

April 10, 2018 at 8:15 AM EDT PDF Version First Personal Genomics Product Will Focus on 59 Genes Identified by the American College of Medical Genetics and Genomics (ACMG) as Highly Penetrant WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 10, 2018– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced a collaboration with Helix, a personal genomics company,... Read more

Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics

SAN DIEGO & STAMFORD, Conn.–(BUSINESS WIRE)–Illumina, Inc. (Nasdaq: ILMN) and Loxo Oncology (Nasdaq: LOXO) today announced a global strategic partnership to develop and commercialize a multi-gene panel for broad tumor profiling, resulting in a distributable, next-generation sequencing (NGS) based companion diagnostic (CDx) with a pan-cancer indication. The co-development partnership will seek approval for a version... Read more

Gilson and Synthace Announce Collaboration Aiming to Make Biological Research More Efficient

Synthace’s Antha Software Makes Gilson’s PIPETMAX More Flexible and Easier to Use MIDDLETON, Wis., LONDON and MUNICH (April 10, 2018) – Analytica 2018 attendees will get a sneak peak of Antha software integrated with PIPETMAX®, a collaboration between Gilson and Synthace launching this summer. The software connects Gilson’s automated liquid handling platform, PIPETMAX, to the cloud... Read more

ATCC Awarded 10-year US Department of Defense Joint Program Executive Office Chemical and Biological Defense JE-RDAP Contract

Providing the DoD with premier biological materials and services MANASSAS, Va., April 6, 2018 /PRNewswire-USNewswire/ — ATCC, a global leader in biological materials development, management and standards, today announced it has been awarded a 10-year contract through the U.S. Department of Defense’s (DoD) Joint Enterprise-Research, Development, Acquisition, and Production/Procurement (JE-RDAP), an omnibus Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle to... Read more

Roche completes acquisition of Flatiron Health

Basel, 06 April 2018 Roche completes acquisition of Flatiron Health Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has completed the acquisition of Flatiron Health, a privately held healthcare technology and services company headquartered in New York City, US. Flatiron Health is a market leader in oncology-specific electronic health record (EHR) software as... Read more

Roche completes acquisition of Flatiron Health

Basel, 06 April 2018 Roche completes acquisition of Flatiron Health Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has completed the acquisition of Flatiron Health, a privately held healthcare technology and services company headquartered in New York City, US. Flatiron Health is a market leader in oncology-specific electronic health record (EHR) software as... Read more

Roche completes acquisition of Flatiron Health

Basel, 06 April 2018 Roche completes acquisition of Flatiron Health Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has completed the acquisition of Flatiron Health, a privately held healthcare technology and services company headquartered in New York City, US. Flatiron Health is a market leader in oncology-specific electronic health record (EHR) software as... Read more

10x Genomics Becomes a Partner in the CanSeq150 Initiative

–CanSeq150 Initiative will use 10x Genomics’ Chromium de novo Assembly Solution to generate high quality, cost-effective assemblies for new genomes– PLEASANTON, CA.—April 5, 2018—10x Genomics, a company focused on accelerating genomic discovery, announced today a partnership with the CanSeq150 Initiative, a sequencing initiative by Canada’s Genomics Enterprise (CGEn). CanSeq150 aims to sequence 150 new genomes... Read more

Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program

April 5, 2018 at 8:15 AM EDT PDF Version WALTHAM, Massachusetts – April 5, 2018 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program.    Duchenne muscular dystrophy (Duchenne) is the most common genetic disorder diagnosed in... Read more

SnapGene and VectorBuilder Partner to Streamline DNA Cloning

April 4, 2018 Biologists can now use SnapGene software to order plasmids directly through VectorBuilder.Chicago, IL – April 4 GSL Biotech and VectorBuilder have formed a partnership to create a complete cloning solution, allowing customers to order their entire custom plasmids directly from VectorBuilder through GSL Biotech’s “SnapGene” software. SnapGene was created to meet the everyday needs of... Read more